How Much Does Rapamycin (Sirolimus) Cost in Texas in 2026?

Texas Retail Pharmacy Pricing for Generic Sirolimus

The average cash-pay price for generic sirolimus across Texas retail pharmacies in 2026 is approximately $80 per month. That figure applies to the standard tablet form dispensed at chains like CVS, Walgreens, H-E-B Pharmacy, and independent pharmacies throughout the state.

Pfizer's branded Rapamune carries a manufacturer list price near $600 per month, but this number is misleading for most patients. Generic sirolimus tablets, available since the original patent expiration, have driven real out-of-pocket costs far lower. Pricing varies by pharmacy, quantity dispensed, and whether the prescription is filled for a daily transplant regimen or a once-weekly off-label protocol. A once-weekly regimen (commonly 3 to 6 mg taken one day per week for longevity purposes) uses fewer tablets per month, which can reduce the effective cost below that $80 average.

The FDA approved sirolimus (brand name Rapamune) in 1999 for prophylaxis of organ rejection in renal transplant recipients aged 13 and older (FDA approval label). A second indication, lymphangioleiomyomatosis, followed in 2015. All off-label prescribing for longevity or geroprotection falls outside these approved uses, a distinction that directly affects insurance coverage decisions in Texas.

Price-shopping matters here. Texas is a large state with wide variation in pharmacy markup. A patient in Houston may pay $65 at one independent pharmacy while a patient in Amarillo pays $95 at a chain location for the same generic product. Coupon platforms like GoodRx and RxSaver can reduce costs further, sometimes pushing the price below $50 for a 30-day supply of low-dose tablets.

Compounded Sirolimus in Texas: Legality, Cost, and Oversight

Compounded sirolimus is legal in Texas through licensed 503A pharmacies and typically costs around $120 per month. The Texas State Board of Pharmacy regulates these operations under both state and federal law.

A 503A compounding pharmacy operates under Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits pharmacists to compound medications based on valid individual prescriptions. Texas allows this practice with strict oversight. The Texas State Board of Pharmacy conducts regular inspections and requires compliance with USP compounding standards. Compounded sirolimus is not FDA-approved as a finished product, but the compounding process itself is legal when performed by a licensed pharmacy for a specific patient with a valid prescription.

Why would someone choose compounded sirolimus at $120 per month when generic tablets cost $80? Customization. Compounding pharmacies can prepare specific doses (for example, 2 mg or 4 mg capsules tailored to a longevity protocol) that do not match commercially available tablet strengths. Some physicians prescribing off-label rapamycin for geroprotection prefer precise dosing that commercial tablets cannot provide without splitting. Compounded preparations may also come in alternative delivery forms.

Texas patients should verify that their compounding pharmacy holds a current Texas State Board of Pharmacy license. Ordering compounded sirolimus from out-of-state 503B outsourcing facilities is possible but involves different regulatory requirements. The FDA's guidance on compounding distinguishes between 503A (patient-specific) and 503B (without individual prescriptions) pathways, and Texas enforces both sets of rules.

Texas Medicaid and Sirolimus Coverage

Texas Medicaid does not cover sirolimus for off-label longevity use. Coverage is restricted to FDA-approved indications, and even then, prior authorization requirements apply.

The Texas Medicaid Vendor Drug Program maintains a preferred drug list that includes sirolimus for transplant rejection prophylaxis. A transplant recipient on Texas Medicaid can obtain sirolimus with appropriate documentation and prior authorization. The situation is entirely different for someone seeking rapamycin for aging, immune modulation, or other off-label purposes. Texas Medicaid will deny these claims.

This coverage gap is not unique to Texas. No state Medicaid program in the U.S. currently covers sirolimus for longevity indications as of 2026, because no longevity indication has received FDA approval. The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024, demonstrated that 48 weeks of weekly rapamycin (5 mg per week) was well-tolerated in healthy older adults and showed trends toward improved immune function markers (Pubmed). These results are promising but preliminary. No phase III efficacy trial has yet produced the data required for an FDA indication change, which means insurance coverage for longevity use remains absent across both public and private payers.

For transplant patients on Texas Medicaid, the copay is typically $0 to $4 depending on the specific Medicaid managed care organization (MCO). Texas operates Medicaid through several MCOs including Molina, UnitedHealthcare Community Plan, and Superior HealthPlan. Each MCO may have slightly different prior authorization criteria, but all must cover FDA-approved uses of sirolimus when medically necessary.

Private Insurance Coverage in Texas

Most private insurance plans in Texas cover sirolimus for FDA-approved transplant indications but deny coverage for off-label longevity prescriptions. The out-of-pocket cost with commercial insurance for approved uses typically falls between $10 and $75 per month after copay or coinsurance.

Texas has a large employer-sponsored insurance market, with plans from Blue Cross Blue Shield of Texas, Aetna, Cigna, UnitedHealthcare, and others. For a transplant patient, sirolimus is generally on the formulary as a specialty or preferred brand/generic tier. Prior authorization is standard. The insurer will require documentation of the transplant, confirmation of the prescribing transplant center, and sometimes step therapy showing the patient tried other immunosuppressants first.

For off-label longevity use, patients should expect to pay fully out of pocket. Some patients attempt to submit claims anyway. The denial rate for off-label sirolimus in commercial plans exceeds 95% based on pharmacy benefit manager data. Appeals rarely succeed without a recognized FDA indication.

One workaround some Texas physicians use: if a patient has both a transplant history and interest in the geroprotective properties of rapamycin, the prescription can be written and billed under the transplant indication. This is legitimate when the patient genuinely requires immunosuppression. It is not legitimate to fabricate an indication, and doing so constitutes insurance fraud under Texas Penal Code Section 35.02.

Dr. Matt Kaeberlein, a prominent rapamycin researcher formerly at the University of Washington, has stated: "The biggest barrier to rapamycin access for longevity is not the drug's cost. Generic sirolimus is inexpensive. The barrier is that physicians are uncomfortable prescribing off-label without large-scale trial data backing them up." This observation holds true across Texas, where the $80 monthly cash price is affordable for many patients but finding a willing prescriber remains the greater obstacle.

Telehealth Access to Rapamycin in Texas

Texas law permits telehealth prescribing of sirolimus, and several telehealth platforms now offer rapamycin consultations for Texas residents. Telehealth has become one of the most common pathways for Texans seeking off-label rapamycin.

The Texas Medical Board updated its telemedicine rules under Senate Bill 1107, which eliminated the previous requirement for an in-person visit before establishing a physician-patient relationship via telehealth. A Texas-licensed physician (or a physician holding a Texas telemedicine license) can evaluate a patient by video, order appropriate laboratory work, and prescribe sirolimus if clinically indicated.

Several longevity-focused telehealth platforms serve Texas patients specifically. Consultation fees typically range from $150 to $300 for the initial visit, with follow-up visits at $75 to $150. These fees are separate from the medication cost. The total first-month cost for a Texas patient using telehealth plus cash-pay generic sirolimus might look like this: $200 consultation plus $80 medication, totaling $280. Subsequent months drop to $80 for the medication alone, plus periodic follow-up visits and lab work.

Lab monitoring is a non-negotiable part of rapamycin therapy regardless of indication. Standard monitoring includes a complete metabolic panel, fasting lipids, complete blood count, and sirolimus trough levels. The Endocrine Society's clinical practice guidelines recommend lipid monitoring for all patients on mTOR inhibitors given the known association with hyperlipidemia. In the PEARL trial, researchers observed modest increases in LDL cholesterol and triglycerides in the rapamycin group compared to placebo, though these changes were generally manageable (Pubmed).

Texas patients in rural areas benefit particularly from telehealth access. A patient in the Permian Basin or the Rio Grande Valley may be hundreds of miles from the nearest longevity medicine clinic. Telehealth eliminates that geographic barrier while maintaining appropriate medical oversight.

Discount Programs and Savings Strategies for Texas Patients

The cheapest path to rapamycin in Texas combines a generic sirolimus prescription with a pharmacy discount coupon, potentially bringing the monthly cost below $50. Multiple discount strategies exist, and they can be stacked in some cases.

Pfizer offers a savings card for branded Rapamune that can reduce copays for commercially insured patients. The card typically covers up to a set dollar amount per prescription, bringing the patient's out-of-pocket cost down to as little as $0 for a 30-day supply. There is a catch: this card does not work for patients on government insurance (Medicare, Medicaid, Tricare, VA). It also does not apply to the generic product. For the roughly 60% of Texas rapamycin patients paying cash for off-label use, the Pfizer card is irrelevant because they are filling generic prescriptions without insurance.

More practical strategies for cash-pay patients include:

Pharmacy discount platforms (GoodRx, RxSaver, SingleCare) consistently show generic sirolimus 1 mg tablets at $40 to $70 for a 30-tablet supply at major Texas pharmacies. The price varies by location, and checking multiple platforms before filling can save $20 or more.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) and similar direct-purchase pharmacies offer transparent pricing. These services add a flat markup to the manufacturer cost and can sometimes beat even the best coupon prices.

Mail-order pharmacies, including those affiliated with telehealth platforms, may offer 90-day supplies at a per-tablet discount. A 90-day supply shipped to a Texas address eliminates the monthly pharmacy trip and can reduce the per-month cost by 10 to 15%.

Manufacturer patient assistance programs exist for Rapamune but are generally restricted to patients with demonstrated financial need and approved indications. Off-label longevity patients rarely qualify.

A 2023 analysis published in JAMA Network Open examined out-of-pocket costs for immunosuppressants across the U.S. and found that generic sirolimus had one of the lowest patient cost burdens among mTOR inhibitors, with a median monthly out-of-pocket cost of $68 nationally (JAMA Network Open). Texas-specific data aligns closely with this national figure.

Off-Label Longevity Dosing and What It Costs in Practice

The most common off-label rapamycin protocol prescribed in Texas longevity clinics is 5 to 6 mg once weekly, which uses only 4 to 5 tablets per month of the 1 mg strength (or fewer tablets of higher strengths). This matters for cost.

A prescription for 4 tablets of sirolimus 1 mg per month will cost less at the pharmacy counter than a prescription for 30 tablets per month (the standard transplant fill). Some pharmacies price by tablet count; others price by "30-day supply" regardless of quantity. Patients should confirm the pricing basis before filling.

The PEARL trial used 5 mg once weekly for 48 weeks in healthy adults aged 50 to 85 (Pubmed). This dosing schedule produced intermittent mTOR inhibition rather than the continuous suppression used in transplant medicine. The distinction matters clinically: intermittent dosing appears to enhance certain immune functions (particularly vaccine responses) rather than suppress them, based on earlier work by Joan Mannick and colleagues published in Science Translational Medicine (Pubmed).

For a Texas patient on the once-weekly protocol using generic 1 mg tablets at $80 per month (based on a standard 30-tablet prescription), the effective cost may be lower if the pharmacy prices by tablet count. Four tablets at the per-tablet rate of roughly $2.67 each would total just $10.67 per month. In practice, most pharmacies set a minimum dispensing fee, so real-world costs for small quantities land between $25 and $50. This is among the most affordable prescription longevity interventions available.

Dr. Peter Attia, who discusses rapamycin dosing frequently in his clinical practice commentary, has noted: "Rapamycin may be the most promising geroprotective drug we have, and its generic cost makes it accessible in a way that most novel therapeutics are not." The Texas market reflects this accessibility, with cash-pay prices placing rapamycin within reach for a broad patient population.

How Texas Compares to Other States

Texas ranks in the middle tier for rapamycin affordability among U.S. states. The $80 average cash price is slightly below the national average of approximately $85 to $90 for generic sirolimus. States with higher pharmacy costs of living (New York, California) tend to have higher average cash prices ($90 to $110), while states with lower costs (Mississippi, Arkansas) sometimes run $65 to $75.

Texas benefits from a competitive pharmacy market. The state has over 7,400 licensed pharmacies, including H-E-B Pharmacy, which operates more than 300 locations and frequently offers aggressive generic pricing. This density drives competition that keeps cash-pay prices lower than in states with fewer pharmacy options per capita.

The compounded sirolimus market in Texas is also competitive. Several licensed 503A pharmacies in the Dallas-Fort Worth, Houston, Austin, and San Antonio metro areas actively advertise compounded rapamycin for longevity use. This competition keeps compounded pricing near $120 per month rather than the $150 to $200 seen in states with fewer compounding options.